» Articles » PMID: 28832542

Solution NMR Spectroscopy in Target-Based Drug Discovery

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2017 Aug 24
PMID 28832542
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Solution NMR spectroscopy is a powerful tool to study protein structures and dynamics under physiological conditions. This technique is particularly useful in target-based drug discovery projects as it provides protein-ligand binding information in solution. Accumulated studies have shown that NMR will play more and more important roles in multiple steps of the drug discovery process. In a fragment-based drug discovery process, ligand-observed and protein-observed NMR spectroscopy can be applied to screen fragments with low binding affinities. The screened fragments can be further optimized into drug-like molecules. In combination with other biophysical techniques, NMR will guide structure-based drug discovery. In this review, we describe the possible roles of NMR spectroscopy in drug discovery. We also illustrate the challenges encountered in the drug discovery process. We include several examples demonstrating the roles of NMR in target-based drug discoveries such as hit identification, ranking ligand binding affinities, and mapping the ligand binding site. We also speculate the possible roles of NMR in target engagement based on recent processes in in-cell NMR spectroscopy.

Citing Articles

Perspectives on Applications of F-NMR in Fragment-Based Drug Discovery.

Li Q, Kang C Molecules. 2024; 29(23).

PMID: 39683906 PMC: 11643073. DOI: 10.3390/molecules29235748.


The importance of choosing the appropriate cholesterol quantification method: enzymatic assay versus gas chromatography.

Serrano J, Martine L, Grosjean Y, Acar N, Alves G, Masson E J Lipid Res. 2024; 65(6):100561.

PMID: 38762123 PMC: 11237936. DOI: 10.1016/j.jlr.2024.100561.


Computer- and NMR-Aided Design of Small-Molecule Inhibitors of the Hub1 Protein.

Reyes Romero A, Kubica K, Kitel R, Rodriguez I, Magiera-Mularz K, Domling A Molecules. 2022; 27(23).

PMID: 36500376 PMC: 9738620. DOI: 10.3390/molecules27238282.


Dengue virus NS4B protein as a target for developing antivirals.

Li Q, Kang C Front Cell Infect Microbiol. 2022; 12:959727.

PMID: 36017362 PMC: 9398000. DOI: 10.3389/fcimb.2022.959727.


NMR spectroscopy in drug discovery and development: Evaluation of physico-chemical properties.

Zloh M ADMET DMPK. 2022; 7(4):242-251.

PMID: 35359618 PMC: 8963582. DOI: 10.5599/admet.737.


References
1.
Lipsitz R, Tjandra N . Residual dipolar couplings in NMR structure analysis. Annu Rev Biophys Biomol Struct. 2004; 33:387-413. DOI: 10.1146/annurev.biophys.33.110502.140306. View

2.
Campos-Olivas R . NMR screening and hit validation in fragment based drug discovery. Curr Top Med Chem. 2010; 11(1):43-67. DOI: 10.2174/156802611793611887. View

3.
Ding K, Gronenborn A . Sensitivity-enhanced 2D IPAP, TROSY-anti-TROSY, and E.COSY experiments: alternatives for measuring dipolar 15N-1HN couplings. J Magn Reson. 2003; 163(2):208-14. DOI: 10.1016/s1090-7807(03)00081-8. View

4.
Ferreon J, Hilser V . Ligand-induced changes in dynamics in the RT loop of the C-terminal SH3 domain of Sem-5 indicate cooperative conformational coupling. Protein Sci. 2003; 12(5):982-96. PMC: 2323869. DOI: 10.1110/ps.0238003. View

5.
Fesik S, Zuiderweg E, Olejniczak E, Gampe Jr R . NMR methods for determining the structures of enzyme/inhibitor complexes as an aid in drug design. Biochem Pharmacol. 1990; 40(1):161-7. DOI: 10.1016/0006-2952(90)90191-m. View